UK govt proposes therapeutic capability clusters to boost pharma
This article was originally published in SRA
The British government has announced plans for a new “life sciences super cluster” to boost translational research and to help deliver the next generation of medicines and technologies needed to support people suffering from chronic diseases1.
You may also be interested in...
The European Medicines Agency is developing a strategy to ensure that women have sufficient information to make informed choices about taking medicines during pregnancy and breastfeeding.
A first-of-its-kind collaborative study has found that real-world and natural history data are comparable to placebo data from clinical trials in Duchenne muscular dystrophy.
An EU group has listed several ambitious projects to help EU regulators realize their cherished vision of using big data capabilities to support innovation and public health. But these proposals may take a backseat as COVID-19-related challenges continue.